Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:0K91 Stock Latest News

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results1w agoQNTM

Company AnnouncementsQuantum BioPharma Wins Consolidation of Market-Manipulation Lawsuits Against CIBC and RBC3w ago6K QNTM
TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial3w agoQNTM
TipRanks NewswireQuantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial3w agoBBIO KRYS
TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial 3w agoQNTM

Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial

Company AnnouncementsQuantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial3w ago6K QNTM

The FlyQuantum BioPharma signs contract with Thermo Fisher for sclerosis trial3w agoTMO QNTM

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing1M agoQNTM

Company AnnouncementsQuantum BioPharma Licensee Unbuzzd Taps New CEO Ahead of Planned Listing1M agoQNTM
The FlyQuantum BioPharma licensee Unbuzzed Wellness appoints Zapolin as CEO1M agoQNTM
TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments1M agoQNTM
Company AnnouncementsQuantum BioPharma Highlights Year of Financing Moves, Debt Settlement and Governance Changes1M ago6K QNTM

Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target 1M agoQNTM

Company AnnouncementsQuantum BioPharma Gains Rodman & Renshaw BUY Rating and US$8 Target1M ago6K QNTM

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit 1M agoQNTM

Company AnnouncementsQuantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth Summit1M ago6K QNTM
Company AnnouncementsQuantum BioPharma to Delist from CSE and Consolidate Trading on Nasdaq2M agoQNTM
TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential2M agoQNTM
The FlyQuantum Group initiated with a Buy at Rodman & Renshaw2M agoQNTM

Quantum BioPharma Grants New Stock Options to Support Growth Initiatives

Company AnnouncementsQuantum BioPharma Grants New Stock Options to Support Growth Initiatives2M agoQNTM

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves2M agoQNTM

TipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 22M agoQNTM